Cultural Adaptation, Validity, and Reliability of the Turkish Version of The PASTUL Questionnaire

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorHacettepe University

About this trial

The Patient Self-Assessment of Skin Thickness in Upper Limb (PASTUL) questionnaire was developed to enable patients to assess skin thickness in systemic sclerosis (SSc) physically and has been validated for reliability and validity, as it correlates with the modified Rodnan Skin Score (mRSS), which rheumatologists assess. Thus, it has been demonstrated to be an applicable and easy approach for assessing skin thickness in SSc patients through patient-reported measurements. This study aimed to develop a Turkish version of the PASTUL questionnaire and to provide for its use in the Turkish population.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Individuals diagnosed with scleroderma,

Individuals aged 18 years and older

Disqualifiers

Advanced heart/lung/liver/kidney disease, neurological disease, and malignancies

Individuals who are unwilling to participate

Trial population

The study population will consist of individuals who come to the university hospital for routine controls.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Questionnaire study

    Other intervention

    Questionnaire application

Treatment groups

50 Participants
are divided into 1 treatment group
Group A: Systemic sclerosis1 intervention

Trial outcomes

Primary outcomes

1

Patient Self-Assessment of Skin Thickness in Upper Limb (PASTUL) Questionnaire

The PASTUL survey is a simple assessment by the patient of the skin in eight areas of the upper extremities as normal, mildly, moderately, or severely thickened, corresponding to the mRSS assessment. The assessment score is consistent with the mRSS (0-3). A high score indicates increased skin thickness

Time frame
Two weeks

Secondary outcomes

1

Scleroderma Health Assessment Questionnaire (SHAQ)

It was developed by adding five questions to the HAQ regarding Raynaud's phenomenon, digital ulcers, gastrointestinal, pulmonary, and general scleroderma symptoms, to be rated on a 15 cm line. The SHAQ total score ranges from 0 to 3. A high score indicates low functionality.

Time frame
Two weeks
2

Cognitive Exercise Therapy Approach-Biopsychosocial Questionnaire (BETY-BQ)

It was standardized as a biopsychosocial assessment tool and is scored using a 5-point Likert scale, with each item rated from 0 to 4 points. A high total score on the 30-item scale indicates a high level of biopsychosocial impact.

Time frame
Two weeks
3

Short Form-36 (SF-36)

It will be used to determine an individual's quality of life levels. Each sub-parameter is scored between 0 and 100 points, with a high score indicating good health status. The SF-36 scale has eight sub-parameters: general health perception, physical function, social function, pain, mental health, role difficulty due to physical reasons, role difficulty due to emotional reasons, and vitality. It contains 11 questions consisting of a total of 36 items.

Time frame
Two weeks
4

Modified Rodnan skin score (MRSS)

A pediatric and adult rheumatologist assessed it. The MRSS evaluates skin thickening in 17 body regions, graded from 0 (normal) to 3 (severe skin thickening). The total score ranges from 0 to 51, with increased scores indicating poor skin involvement.

Time frame
Two weeks

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.